Statistics for Bcl‑2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose‑dependent toxicity and resistance
Total visits
| views | |
|---|---|
| Bcl‑2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose‑dependent toxicity and resistance | 0 |
Total visits per month
| views | |
|---|---|
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
File Visits
| views | |
|---|---|
| leisching_bcl2_2015.pdf | 16 |